A1D5U

Dexmethylphenidate

Created:	2024-01-31
Last modified:	2025-08-25

Find Related PDB Entry
1 entries where A1D5U is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	36
Chiral Atom Count	2
Bond Count	37
Aromatic Bond Count	6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Dexmethylphenidate
Systematic Name (OpenEye OEToolkits)	methyl (2~{R})-2-phenyl-2-[(2~{R})-piperidin-2-yl]ethanoate
Formula	C₁₄ H₁₉ N O₂
Molecular Weight	233.306
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	COC(=O)[CH]([CH]1CCCCN1)c2ccccc2
SMILES	OpenEye OEToolkits	2.0.7	COC(=O)C(c1ccccc1)C2CCCCN2
Canonical SMILES	CACTVS	3.385	COC(=O)[C@@H]([C@H]1CCCCN1)c2ccccc2
Canonical SMILES	OpenEye OEToolkits	2.0.7	COC(=O)[C@H](c1ccccc1)[C@H]2CCCCN2
InChI	InChI	1.06	InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1
InChIKey	InChI	1.06	DUGOZIWVEXMGBE-CHWSQXEVSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB06701
Name	Dexmethylphenidate
Groups	investigational approved
Description	Dexmethylphenidate is the dextrorotary form of methylphenidate introduced in 2002[A177181]. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant[A177193]. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD)[Label,A177181]. The d-isomer is thought to have greater effect with fewer side effects than the l-isomer or the racemic mixture[A177181].
Synonyms	Dexmethylphenidatum d-threo-methylphenidate D-TMP Dexmethylphenidate (+)-threo-methylphenidate methyl (R)-phenyl[(R)-piperidin-2-yl]acetate Dexméthylphénidate Dexmethylphenidate hydrochloride Dexmetilfenidato
Brand Names	Dexmethylphenidate Hydrochloride Dexmethylphenidate HCl Azstarys Attenade FocalinXR Focalin XR Dexmethylphenidate hydrochloride Dexmethylphenidate Hydrochloride Extended-Release Focalin
Indication	Dexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment[A177187,Label].
Categories	Agents that produce hypertension Antidepressive Agents Central Nervous System Agents Central Nervous System Depressants Central Nervous System Stimulants Central Nervous System Stimulation Centrally Acting Sympathomimetics Combined Inhibitors of Serotonin/Norepinephrine Reuptake Dopamine Agents Dopamine Uptake Inhibitors Membrane Transport Modulators Methylphenidate and isomer Nervous System Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Phenylacetates Piperidines Psychoanaleptics Psychostimulants, Agents Used for ADHD and Nootropics Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin Agents Serotonin Modulators
ATC-Code	N06BA11 N06BA15
CAS number	40431-64-9

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Sodium-dependent dopamine transporter	MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP...	unknown	inhibitor
Sodium-dependent noradrenaline transporter	MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD...	unknown	inhibitor
Sodium-dependent serotonin transporter	METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAV...	unknown	inhibitor
Carboxylesterase	MWLRAFILATLSASAAW	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682